Of those with uncontrolled blood pressure, more than 6 in 10 are not taking antihypertensive medication. HealthDay News — Most US adults with uncontrolled blood pressure (BP) are not taking ...

HealthDay News — For human papillomavirus (HPV) testing for detection of cervical intraepithelial neoplasia grade 2/3 or worse (CIN2+/CIN3+), minipad-collected menstrual blood shows comparable ...

HealthDay News — Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws.

The table below is a review of notable updates that occurred in January 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Breakthrough Therapy status for rilzabrutinib in wAIHA addresses the lack of approved treatments for this rare and life-threatening condition.

HealthDay News — The US Food and Drug Administration (FDA) will now allow food labels to claim products have “no artificial colors” as long as they avoid petroleum-based dyes.

Decrease in male-to-female ratio seen with increasing age at diagnosis and by calendar period for those aged older than 10 years ...

Fewer interval cancers that were invasive, T2+, or non-luminal A were found in group with AI-supported mammography versus standard double reading ...

Another major medical group says most gender-related surgeries for minors in the US should be postponed until adulthood. The American Medical Association (AMA) said Wednesday that surgical ...

HealthDay News — For early-morning shift workers with shift work disorder (SWD), treatment with solriamfetol significantly improves sleepiness, according to a study published in the February issue of ...

HealthDay News — More than 31,000 nurses and health care workers walked off the job Monday morning at Kaiser Permanente ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...